$79.16 0.6%
AZN Stock Price vs. AI Score
Data gathered: July 23

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Astrazeneca

AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer, immunology, and neuroscience.

Price $79.16
Target Price Sign up
Volume 3,140,000
Market Cap $245B
Year Range $60.11 - $80.83
Dividend Yield 1.84%
PE Ratio 38.97
Earnings Date July 25 '24
Industry Drug Manufacturers

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2412.7B3.14B9.54B2.18B4.5B1.030
Q4 '2312B2.31B9.72B960M2.91B0.730
Q3 '2311.5B2.1B9.4B1.37B3.33B0.870
Q2 '2311.4B1.96B9.46B1.82B2.52B1.080
Q1 '2310.9B1.91B8.97B1.8B3.89B0.960

Insider Transactions View All

No recorded Insider transactions.

Congress Trading View All

Politician Filing Date Type Size
Rohit Khanna
Nov 8, 23 Buy $1K - $15K
Michael McCaul
Sep 20, 23 Sell $100K - $250K
Michael McCaul
Sep 20, 23 Sell $50K - $100K

What is the Market Cap of Astrazeneca?

The Market Cap of Astrazeneca is $245B.

What is Astrazeneca's PE Ratio?

As of today, Astrazeneca's PE (Price to Earnings) ratio is 38.97.

When does Astrazeneca report earnings?

Astrazeneca will report its next earnings on July 25 '24.

What is the current stock price of Astrazeneca?

Currently, the price of one share of Astrazeneca stock is $79.16.

How can I analyze the AZN stock price chart for investment decisions?

The AZN stock price chart above provides a comprehensive visual representation of Astrazeneca's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Astrazeneca shares. Our platform offers an up-to-date AZN stock price chart, along with technical data analysis and alternative data insights.

Does AZN offer dividends to its shareholders?

Yes, Astrazeneca (AZN) offers dividends to its shareholders, with a dividend yield of 1.84%. This dividend yield represents Astrazeneca's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Astrazeneca in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Astrazeneca?

Some of the similar stocks of Astrazeneca are Johnson & Johnson, Eli Lilly and Company, Pfizer, AbbVie, and TherapeuticsMD.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.